These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12856058)

  • 1. Plasmodium falciparum outwits Malarone, protector of travellers.
    Crabb C
    Bull World Health Organ; 2003; 81(5):382-3. PubMed ID: 12856058
    [No Abstract]   [Full Text] [Related]  

  • 2. [What is the value of the combination atovaquone-proguanil for the clinician?].
    Delmont J
    Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
    Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
    J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
    Wichmann O; Muehlberger N; Jelinek T; Alifrangis M; Peyerl-Hoffmann G; Muhlen M; Grobusch MP; Gascon J; Matteelli A; Laferl H; Bisoffi Z; Ehrhardt S; Cuadros J; Hatz C; Gjorup I; McWhinney P; Beran J; da Cunha S; Schulze M; Kollaritsch H; Kern P; Fry G; Richter J;
    J Infect Dis; 2004 Nov; 190(9):1541-6. PubMed ID: 15478057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atovaquone-proguanil resistance in imported falciparum malaria in a young child.
    Rose GW; Suh KN; Kain KC; Le Saux N; McCarthy AE
    Pediatr Infect Dis J; 2008 Jun; 27(6):567-9. PubMed ID: 18434932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malarone: a new antimalarial for malaria chemoprevention].
    Delmont J
    Med Trop (Mars); 2002; 62(1):19-21. PubMed ID: 12038171
    [No Abstract]   [Full Text] [Related]  

  • 8. [Atovaquone/proguanil. Prophylaxis and treatment of malaria].
    Lundgren JD; Dragsted UB
    Ugeskr Laeger; 2000 Jul; 162(31):4177-81. PubMed ID: 10962933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malarone: newcomer in the treatment of malaria].
    Touze JE; Fourcade L
    Med Trop (Mars); 1997; 57(3):225-7. PubMed ID: 9513142
    [No Abstract]   [Full Text] [Related]  

  • 10. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
    Kuhn S; Gill MJ; Kain KC
    Am J Trop Med Hyg; 2005 Apr; 72(4):407-9. PubMed ID: 15827276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E; Bujanover S; Kain KC
    Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atovaquone/proguanil for the prophylaxis and treatment of malaria.
    Patel SN; Kain KC
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):849-61. PubMed ID: 16307498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
    Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
    Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [symbol: see text] Atovaquone + proguanil for malaria prophylaxis.
    Drug Ther Bull; 2001 Oct; 39(10):73-5. PubMed ID: 11706518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of atovaquone in human sera following treatment: inhibition of Plasmodium falciparum development in vivo and in vitro.
    Butcher GA; Sinden RE
    Am J Trop Med Hyg; 2003 Jan; 68(1):111-4. PubMed ID: 12556158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil.
    Thapar MM; Gil JP; Björkman A
    Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):62-70. PubMed ID: 15550263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.
    Edstein MD; Kotecka BM; Anderson KL; Pombo DJ; Kyle DE; Rieckmann KH; Good MF
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4421-2. PubMed ID: 16189139
    [No Abstract]   [Full Text] [Related]  

  • 18. Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border.
    Naoshima-Ishibashi Y; Iwagami M; Kawazu S; Looareesuwan S; Kano S
    Travel Med Infect Dis; 2007 Mar; 5(2):132-4. PubMed ID: 17298921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies using the combination atovaquone-proguanil as malaria prophylaxis in non-immune adult and child travelers].
    Camus D; Dutoit E; Masson V; Inglebert P; Delhaes L
    Med Trop (Mars); 2002; 62(3):225-8. PubMed ID: 12244915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience with the combination atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria--report of 112 cases].
    Malvy D; Djossou F; Vatan R; Pistone T; Etienne G; Longy-Boursier M; Le Bras M
    Med Trop (Mars); 2002; 62(3):229-31. PubMed ID: 12244916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.